News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Galectin Therapeutics To Hold Conference Call To Provide Corporate Update Following Company's Annual Meeting Of Shareholders


5/8/2014 10:06:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ATLANTA, May 8, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics (Nasdaq:GALT) will host a conference call at 9:45 A.M. Eastern Time on Wednesday, May 14, 2014, to provide a corporate update following the Company's Annual Meeting of Shareholders. Additionally, Peter Traber, MD, President, CEO and CMO of Galectin Therapeutics, will update the investment community on the Company's pipeline of galectin inhibitor compounds and progress in development of treatments for liver fibrosis and cancer.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES